Clostridium tyrobutyricum

Clostridium butyricum is a spore-forming anaerobic bacterium capable of producing butyric acid through fermentation.

Clostridium butyricum MIYAIRI 588 is a spore-forming, butyrate-producing bacterium approved as a probiotic in Japan and studied for its effects on intestinal health.

Clostridium leptum is an anaerobic gut bacterium that belongs to a numerically significant group of microbes in the human intestine, often used as a biomarker in microbiome composition studies.

Clostridium sporogenes is an anaerobic, spore-forming bacterium that is not a recognized probiotic.

Faecalibacterium prausnitzii is a butyrate-producing commensal bacterium that is among the most abundant in a healthy human gut and has attracted significant research interest as a potential next-generation probiotic.

Clostridium butyricum MIYAIRI 588 (CBM588) is a spore-forming, butyrate-producing bacterium studied in the context of gut health and, more recently, oncology.